Rajani Jagana
Professor
Also affiliated: University of Arkansas Medical Center (2017–2022); Central Arkansas Veterans Healthcare System (2015); University of Kansas Medical Center (2022)
Faculty Researcher
Internal Med, College of Medicine
Research Areas
Biomedical Subjects
Biography and Research Information
OverviewAI-generated summary
Rajani Jagana's research focuses on pulmonary arterial hypertension, investigating the influence of iron deficiency on clinical and hemodynamic parameters within patient cohorts. Jagana has also studied the association between tocilizumab use and an increased risk of fungal infections in critically ill patients with COVID-19 and acute renal failure. Other areas of investigation include the presentation of pulmonary emboli with ST-elevation on electrocardiograms, and the efficacy of personal protective equipment in healthcare emergencies. Jagana's work contributes to understanding complex clinical conditions and the management of associated risks. Jagana has published 41 papers, with a total of 120 citations and an h-index of 7. Key collaborators include Nikhil Meena, MOHAMMAD KHRAIS, Arjun Rao, and William T. Atchley, all from the University of Arkansas for Medical Sciences, with whom Jagana has co-authored multiple publications.
Metrics
- h-index: 7
- Publications: 41
- Citations: 124
Selected Publications
-
Successful Management of ETI-Induced-Urticaria (2025)
-
A Case of Hydroxychloroquine Associated Catatonia in SLE (2025)
-
Reduction of Methicillin-resistant Staphylococcus Aureus (MRSA) Acquisition in Patients With Cystic Fibrosis: Single-center Quality Improvement Project (2025)
-
Idiopathic Hypereosinophilic Syndrome in a Rare Case of Quadricuspid Aortic Valve (2024)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study (2023)
-
Influence of Iron Deficiency on Clinical and Haemodynamic Parameters in Pulmonary Arterial Hypertension Cohorts (2022)
-
A Rare Case of Pulmonary Emboli Presenting With ST Elevation on ECG (2022)
-
Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience (2022)
-
Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study. (2021)
-
Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 (2021)
-
Guillain-Barre Syndrome or Is It? (2020)
-
Cystic Fibrosis Presenting as Chronic Cough in Elderly (2020)
-
Noncystic fibrosis bronchiectasis management (2019)
-
Częstość readmisji i jej predyktory u chorych na mukowiscydozę w Stanach Zjednoczonych (2018)
-
Acute Influenza Infection Presenting with Cardiac Tamponade: A Case Report and Review of Literature (2018)
Research Interests
1. Cystic Fibrosis: I have done and been doing many research projects in field of cystic fibrosis in collaboration with Cystic Fibrosis Foundation. These international and multicenter center studies have made an impact in the lives of cystic fibrosis patients by increasing their estimated life survival and decreased hospitalizations. I am principal investigator of few ongoing multicenter studies and sub-investigator of multiple studies at our center in the field of Cystic fibrosis and non CF bronchiectasis. 2. COVID-19: I am sub-investigator of multiple COVID-19 studies currently undergoing in our Institution. 3. I involve students, residents and fellows in research projects and may of these projects and case reports have been presented in national and international pulmonary and critical care conferences 4. I have authored 7 manuscripts, which have been published in peer- reviewed international medical journals. In addition, I have made over 26 posters and presentations that have been showcased at the international conferences including American Thoracic Society, American college of physicians (ACP), society of critical care medicine (SCCM) and CHEST conferences.
Grants & Funding
As listed on this researcher's institutional profile.
- LEAPP CF: Leadership and Education Advanced Practice Provider Fellow Program in CF 2023 Cystic Fibrosis Foundation Principal Investigator
- CFF Care Center Award 2021_2022 Cystic Fibrosis Foundation Co-Investigator
- A Phase 2, Open-label, Multiple Ascending-Dose Study to Evaluate the Safety, Tolerability and Efficacy of ARCT-032 in People with Cystic Fibrosis (IRB 298318) Arcturus Therapeutics, Inc. via Worldwide Clinical Trials, Inc Principal Investigator
- Cystic Fibrosis Care Centers -2020-2021 Continuation - Continuation - Continuation Cystic Fibrosis Foundation Co-Investigator
Collaboration Network
Top Collaborators
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Tocilizumab Is Associated with Increased Risk of Fungal Infections among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study
- Tocilizumab is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19 and Acute Renal Failure: An Observational Cohort Study.
- Tocilizumab Is Associated with Increased Risk of Fungal Infections Among Critically Ill Patients with COVID-19
- Successful Management of ETI-Induced-Urticaria
- Idiopathic Hypereosinophilic Syndrome in a Rare Case of Quadricuspid Aortic Valve
- Reduction of Methicillin-resistant Staphylococcus Aureus (MRSA) Acquisition in Patients With Cystic Fibrosis: Single-center Quality Improvement Project
- Successful Management of ETI-Induced-Urticaria
- Reduction of Methicillin-resistant Staphylococcus Aureus (MRSA) Acquisition in Patients With Cystic Fibrosis: Single-center Quality Improvement Project
- A Case of Hydroxychloroquine Associated Catatonia in SLE
- Successful Management of ETI-Induced-Urticaria
- Personal Protective Equipment Efficiency in Healthcare Emergencies: A Single-Center Experience
- A Rare Case of Pulmonary Emboli Presenting With ST Elevation on ECG
- A Rare Case of Pulmonary Emboli Presenting With ST Elevation on ECG
- Idiopathic Hypereosinophilic Syndrome in a Rare Case of Quadricuspid Aortic Valve
- Idiopathic Hypereosinophilic Syndrome in a Rare Case of Quadricuspid Aortic Valve
- Reduction of Methicillin-resistant Staphylococcus Aureus (MRSA) Acquisition in Patients With Cystic Fibrosis: Single-center Quality Improvement Project
- A Case of Hydroxychloroquine Associated Catatonia in SLE
Similar Researchers
Based on overlapping research topics